Filtered By:
Cancer: Prostate Cancer
Countries: USA Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 616 results found since Jan 2013.
Epigenetic mechanism of therapeutic resistance and potential of epigenetic therapeutics in chemorefractory prostate cancer
Int Rev Cell Mol Biol. 2023;380:173-210. doi: 10.1016/bs.ircmb.2023.03.012. Epub 2023 Apr 12.ABSTRACTProstate cancer is the second leading cause of cancer death among men in the United States. Depending upon the histopathological subtypes of prostate cancers, various therapeutic options, such as androgen deprivation therapy (ADT), androgen receptor signaling inhibitors (ARSI), immunotherapy, and chemotherapy, are available to treat prostate cancer. While these therapeutics are effective in the initial stages during treatments, the tumors subsequently develop resistance to these therapies. Despite all the progress made so f...
Source: International Review of Cell and Molecular Biology - September 1, 2023 Category: Cytology Authors: Priti Roy Kamaleshwar P Singh Source Type: research
